Emerald Health Sciences Inc., a 10% Holder, acquired 9,713,666 Common Shares on a direct ownership basis at a price of $0.290 through a prospectus or prospectus exempt offering on January 31st, 2020. This represents a $2,816,963 investment into the company's shares and an account share holdings change of 32.7%.
Emerald Health Therapeuti is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Emerald Health Therapeutics Inc is a Canada-based company engaged in the medical marijuana industry. The Company operates through Emerald Health Botanicals Inc (Botanicals), a wholly owned subsidiary and Licensed Producer under Canada's Access to Cannabis for Medical Purposes Regulations. Through Botanicals, the Company is authorized to produce and sell dried cannabis flower and cannabis oil for medical purposes. The Company operates an indoor cultivation facility in Victoria, British Columbia and, through Pure Sunfarms Corp, a joint venture with Village Farms International Inc, expands into additional greenhouses. The Company also offers analytical testing of cannabis through an interest in Northern Vine Canada Inc, a Licensed Dealer under Canadian Controlled Drugs and Substances Act. The Company is part of the Emerald Health Group, which is focused on developing pharmaceutical, botanical and nutraceutical products designed to interact with the human body's endocannabinoid system. Emerald Health Therapeutics, Inc. (EMH) has below median officer and director direct ownership compared to its micro-cap peers in the market, based on our estimate using SEDI data. According to recent regulatory filings, one insider has invested a total amount of $2,816,963.
No Comments